TI
SRPT icon

Tidal Investments’s Sarepta Therapeutics SRPT Stock Holding History

Tidal Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,972
Closed -$361K – 2010
2024
Q4 		$361K Sell
2,972
-2,662
-47% -$326K ﹤0.01% 1525
2024
Q3 		$704K Buy
5,634
+2,688
+91% +$372K 0.01% 1210
2024
Q2 		$465K Buy
2,946
+44
+2% +$5.65K 0.01% 1335
2024
Q1 		$376K Buy
2,902
+228
+9% +$27.9K 0.01% 1311
2023
Q4 		$258K Buy
2,674
+735
+38% +$70.5K 0.01% 1235
2023
Q3 		$235K Buy
1,939
+111
+6% +$12.5K 0.01% 1152
2023
Q2 		$209K Buy
+1,828
New +$236K 0.01% 1190

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Tidal Investments's SRPT Position: Q1 2025 in Review

Tidal Investments sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 2,972 shares — an estimated $361K sold.

Tidal Investments first reported a position in SRPT in Q2 2023 and held it in 7 quarters. The position peaked at $704K in Q3 2024. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

  • Tidal Investments reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Tidal Investments sold 2,972 Sarepta Therapeutics shares in Q1 2025, an estimated $361K.
  • Tidal Investments first reported a position in Sarepta Therapeutics in Q2 2023 and held it in 7 quarters.
  • Tidal Investments's Sarepta Therapeutics position peaked at $704K in Q3 2024.
  • 430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Tidal Investments's 13F filing for Q1 2025, filed 14 May 2025.